ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,105Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 28

$523K Total Retail Price of All Prescriptions

Rank: 8 out of 28

153 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 153 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,865 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $222 among peers.

Prescriptions per Patient

60 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
WARFARIN SODIUM 520 520 1 3
LEVOTHYROXINE SODIUM 348 337 2 5
ESCITALOPRAM OXALATE 291 229 3 24
SIMVASTATIN 264 230 4 6
DONEPEZIL HCL 259 258 5 16
FUROSEMIDE 257 229 6 4
POTASSIUM CHLORIDE 252 234 7 12
NAMENDA 251 230 8 21
LISINOPRIL 229 221 9 17
AMLODIPINE BESYLATE 219 212 10 11
OMEPRAZOLE 204 176 11 15
HYDROCODONE-ACETAMINOPHEN 179 157 S3 12 1
GABAPENTIN 163 138 13 13
QUETIAPINE FUMARATE 160 140 14 28
METOPROLOL TARTRATE 129 117 15 18
LIDODERM 120 117 16 30
CITALOPRAM HBR 120 115 16 31
SERTRALINE HCL 116 104 18 23
METFORMIN HCL 113 77 19 31
FAMOTIDINE 104 98 20 34
EXELON 89 89 21 54
CARVEDILOL 87 68 22 37
RISPERIDONE 84 65 23 56
LANTUS 79 64 24 41
DIGOXIN 78 78 25 43
ISOSORBIDE MONONITRATE ER 77 72 26 59
NOVOLOG 76 60 27 42
IPRATROPIUM-ALBUTEROL 76 76 27 39
ALLOPURINOL 71 68 29 61
DIVALPROEX SODIUM 69 33 30 63
CYMBALTA 65 52 31 46
LEXAPRO 64 52 32 67
ALENDRONATE SODIUM 63 56 33 44
TRAZODONE HCL 63 52 33 68
MIRTAZAPINE 62 62 35 37
BACLOFEN 62 0 35 69
DOXYCYCLINE HYCLATE 61 57 37 2
METOCLOPRAMIDE HCL 57 24 38 74
JANUVIA 55 44 39 79
TAMSULOSIN HCL 55 50 39 48
FLUTICASONE PROPIONATE 55 54 39 79
LACTULOSE 53 34 42 84
HYDROCHLOROTHIAZIDE 53 53 42 47
SANTYL 51 36 44 89
NYSTATIN 51 44 44 89
PANTOPRAZOLE SODIUM 50 25 46 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.